Brind.

Engitix Appoints Sonia Quaratino as EVP Chief Medical Officer

2 reports, 1 independent Updated Wed 00:00
No new developments lately Reached 2 outlets in its first 24 hours
Reports
2
Developments
1
Repetition
50%

New informationRepeats or wire copies

AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Engitix Ltd., a biotechnology company focused on extracellular matrix (ECM)-based discovery platforms, announced the appointment of Sonia Quaratino as Executive Vice President (EVP) Chief Medical Officer (CMO). Dr. Quaratino brings over 35 years of experience in immunology, oncology, and clinical development. She will be responsible for all aspects of the company’s clinical and medical strategy. Giuseppe Mazza remains Co-Founder and CEO of Engitix.

From manilatimes.net

Why it matters

Some supportBrind's analysis of the reports

The appointment strengthens Engitix’s clinical and translational leadership as the company advances its pipeline of ECM-targeting therapeutics. The company focuses on drug development in oncology, fibrosis, and fibro-inflammatory diseases.

From manilatimes.net

Who's involved

  • CMOChief Medical Officer appointment

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
1 more outlet ran the same wire story